Insights

Gathering insights about AMIS…

Similar companies to AMIS

AMIS Tech Stack

AMIS uses 8 technology products and services including WordPress, oEmbed, Modernizr, and more. Explore AMIS's tech stack below.

WordPress
Content Management System
oEmbed
Dev Tools
Modernizr
Javascript Libraries
Lightbox
Javascript Libraries
Debian
Operating Systems
X-XSS-Protection
Security
Google Analytics
Web Analytics
Agosto
Web Design And Development Services

Media & News

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
Company to begin trading under new ticker symbol “DMK” on September 8, 2023 Company to begin trading under new ticker symbol “DMK” on September 8, 2023
Sep 07, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments.
Aug 21, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $1.35. The common warrants are immediately exercisable at a price of $1.35 per share and expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants were only purchasable together in this offering, but were issued separately and immediately separable upon issuance.
Aug 04, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing of its public offering of 5,930,000 units at a public offering price of $1.35 per unit. Each unit consists of one share of common stock (or a prefunded warrant in lieu thereof) and one warrant to purchase one share of common stock. The common warrants will be immediately exercisable at an exercise price of $1.35 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.
Aug 02, 2023 | www.globenewswire.com
Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the Company has committed to fund an unrestricted research grant to the Leiden University Medical Center (LUMC) Anesthesia and Pain Research Unit. The funding will support the work of Albert Dahan, MD, PhD, a world expert on opioid-induced respiratory depression (opioid overdose) and professor of anesthesiology at the University. Dr. Dahan has been working with the FDA since 2020 to understand better methods of reversing fentanyl overdoses.
Jul 28, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder
SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that its wholly owned subsidiary DMK Pharmaceuticals Corporation was the recipient of a grant from the National Institute on Alcohol Abuse And Alcoholism (NIAAA) of the National Institutes of Health (NIH) to support the development of a novel bifunctional small molecule for the treatment of Alcohol Use Disorder (AUD) (#R41AA030226).
Jun 26, 2023 | www.globenewswire.com
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis Pharmaceuticals is proud and excited to have participated in the White House Roundtable with Opioid Reversal Product Manufacturers, hosted by White House Office of National Drug Control Policy Director, Dr. Rahul Gupta, White House Domestic Policy Council Advisor Neera Tanden, U.S. Assistant Secretary for Health Admiral Rachel Levine, and U.S. Assistant Secretary for Mental Health and Substance Use Dr. Miriam E. Delphin-Rittmon. Dr. Gupta is the first medical doctor to ever lead the White House Office of National Drug Control Policy (ONDCP). ONDCP is responsible for the development and implementation of the National Drug Control Strategy and Budget. The roundtable discussion was held on June 20, 2023.
Jun 22, 2023 | www.globenewswire.com

AMIS's Email Address Formats

AMIS uses at least 2 format(s):

AMIS Email Formats	Example	Percentage
FLast@amis.com.mx	JDoe@amis.com.mx	91%
FiMLast@amis.com.mx	JoMDoe@amis.com.mx	9%

Frequently Asked Questions

Where is AMIS's headquarters located?

AMIS's main headquarters is located at Mexico City, Mexico City 01040 Mexico. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is AMIS's stock symbol?

AMIS is a publicly traded company; the company's stock symbol is ADMP.

What is AMIS's official website and social media links?

AMIS's official website is sitio.amis.com.mx and has social profiles on LinkedIn.

What is AMIS's NAICS code?

AMIS's NAICS code is 524 - Insurance Carriers and Related Activities.

How many employees does AMIS have currently?

As of June 2026, AMIS has approximately 422 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Cfo - Director Of Finance And Administration: R. C.Cybersecurity President At The Association Of Mexican Insurance Companies (amis): M. P. B.Gerente De Project Manager Office: L. R. B.. Explore AMIS's employee directory with LeadIQ.

What industry does AMIS belong to?

AMIS operates in the Insurance industry.

What technology does AMIS use?

AMIS's tech stack includes WordPressoEmbedModernizrLightboxDebianX-XSS-ProtectionGoogle AnalyticsAgosto.

What is AMIS's email format?

AMIS's email format typically follows the pattern of FLast@amis.com.mx. Find more AMIS email formats with LeadIQ.

When was AMIS founded?

AMIS was founded in 1964.

AMIS

Q: What is AMIS's official website and social media links?

AMIS's official website is sitio.amis.com.mx. AMIS has social profiles on LinkedIn.

Q: How many employees does AMIS have currently?

AMIS has approximately 422 employees.

Q: What technology does AMIS use?

AMIS's tech stack includes Swiper, Microsoft 365, WordPress, jQuery Validation Plugin, Contact Form 7.

Q: What is AMIS's NAICS code?

AMIS's NAICS code is 524 (Insurance Carriers and Related Activities).

InsuranceMexico City, Mexico201-500 Employees

AMIS is a Mexican industry association focused on developing and advancing the insurance sector. Its core objective is to represent the interests of the insurance industry before public, private, and social sectors, while promoting risk prevention and the use of insurance as a protective mechanism. Based in Mexico City, the organization serves as a focal point for stakeholders across the insurance ecosystem, supporting a culture of risk awareness and the professionalization of the industry. With a membership footprint that places it among mid-sized professional bodies in the sector, AMIS aims to facilitate dialogue, policy-facing activities, and industry-wide collaboration to strengthen the Mexican insurance landscape.